Syngenta Group completed the acquisition of Valagro from Metalmark Capital for £455m.

Syngenta Group, a maker of crop produces agrochemical products, completed the acquisition of Valagro, a biologicals company, from Metalmark Capital, a private equity firm, for £455m. “We are looking forward to welcoming the Valagro team to Syngenta Group. This acquisition underlines our growth ambitions in this area and positions us as one of the strongest players in the global biologicals market. The investment also forms part of our $2bn commitment to help farmers address the effects of climate change and improve agricultural sustainability as part of our Good Growth Plan,” Erik Fyrwald, Syngenta Group CEO.